MongoDB is benefiting from deeper adoption among large enterprises, with nearly 3,000 customers generating at least $100,000 in annual recurring revenue in fiscal Q2 2027, up 17% year over year. Atlas revenue rose about 29% year over year, the fifth consecutive quarter of such growth, with a record $127 million increase. Total net ARR expansion rose to 122% from 119%, and 48% of Atlas customers with at least $100,000 in ARR used two or more features, up from 42%. MongoDB raised its fiscal 2027 Atlas growth outlook to about 27%, up 300 basis points from the midpoint of its prior guidance. Competitors include Amazon's DocumentDB and Microsoft's Azure Cosmos DB, while MDB shares are down 15.1% year to date against a 19.2% gain for the Zacks Computer and Technology sector.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Related news
- Can ARM's 13% Contract Value Growth Sustain Momentum in Q2?
Arm Holdings' annualized contract value (ACV) reached $1.73 billion in fiscal Q1 2027, up 13% from $1.53 billion a year earlier and from $1.66 billion in fiscal Q4 2026. Licensing and other revenues rose 23% year over year to $574 million, and royalty revenues climbed 22% to $715 million on broader adoption of newer architectures. The article says these trends set a favorable backdrop for the upcoming fiscal Q2 report, but flags the timing of large licensing deals, variability in customer spending, customer concentration and elevated R&D expenses as key concerns. It also points to Qualcomm and NVIDIA as U.S.-listed semiconductor peers benefiting from demand for advanced computing.
- Nectar Launches Customer Atlas, Extending Amazon Marketing Cloud Audience Targeting From Display Into Search Bidding
Nectar, an Amazon Advanced Advertising Partner managing more than $2.5 billion in annual client sales, launched Customer Atlas, an Amazon Marketing Cloud capability that targets shoppers rather than keywords in Amazon search advertising. The tool indexes up to five years of a brand's purchase history against all 6,728 Amazon audience segments (5,268 in-market and 1,460 lifestyle), producing a targeting list of high-value buyers and a suppression list of people who buy once and never return. These lists are applied in Amazon DSP and as audience bid modifiers in Sponsored Products and Sponsored Brands, with a low base bid that rises only when a targeted shopper searches, and no new campaigns are needed because the budget is already committed. In one engagement, the largest category segment reached 24.9 million shoppers but showed no link to repeat purchase, while far smaller segments predicted it strongly. Nectar's Chief Strategy Officer Youval Peltier said audience targeting on Amazon had been wrongly classed as a display tactic and can now be used inside search.
- Can Tesla Sustain China EV Sales Growth Amid Competition?
Tesla's September 2026 shipments of China-built Model 3 and Model Y vehicles, including exports, rose 5% year over year to 95,366 units, extending its growth streak to 11 months, according to the China Passenger Car Association. Shanghai-built EV sales rose 13.7% in the third quarter, though Tesla's global deliveries fell 2.1% from a record 2025 quarter. Tesla ranked sixth among China's new energy vehicle makers, behind BYD with 233,943 units, and is offering final payment discounts through October of 7,000 yuan on selected Model Y variants and 5,000 yuan on Model 3, which may weigh on margins. Rivals are also growing: NIO delivered 37,408 vehicles, up 7.7%, while BYD sold 463,561 new energy vehicles, up 17%, with exports up 153.9%.
- Can broadening earnings growth sustain the equity upcycle? JPM weighs in
JPMorgan strategists led by Mislav Matejka say third-quarter earnings should reassure investors as strength broadens beyond AI, even though headline expectations look elevated. Consensus expects S&P 500 Q3 EPS growth of 24% per IBES, or 30% per FactSet and LSEG after adjusting for a one-off Meta tax charge; excluding Nvidia and Micron the hurdle falls to 15%, and to 8% for the median stock. European growth is expected at 19% (11% excluding energy), while global PMIs hit multi-year highs and the earnings lead indicator is still rising, suggesting at least the next two seasons should be positive. A sharp bond yield spike is nearing oversold levels, and if yields peak as results start, equities could advance into year-end. JPMorgan remains positive on European semiconductors, banks, chemicals and industrials.
- Can Gaming Pipeline and Activision Add Momentum to Microsoft Stock?
Microsoft is counting on a busy fall gaming lineup to revive Xbox, with Gears of War: E-Day launched on Oct. 6 for Game Pass subscribers and Call of Duty: Modern Warfare 4 arriving Oct. 23 without Game Pass at launch. Management expects Xbox content and services revenue to fall in the mid-single digits in the first quarter of fiscal 2027, though it still targets a return to growth that year. Fiscal 2026 Xbox revenue dropped 7%, or $1.7 billion, and Xbox makes up about 5.5% of Microsoft's $90 billion fourth-quarter revenue, so the article argues gaming alone is unlikely to be a major stock catalyst. Rivals show uneven trends: Take-Two's first-quarter net bookings fell 3% to $1.39 billion, yet it kept its $8–$8.2 billion guidance tied to the Nov. 19 GTA VI launch, while Roblox's second-quarter bookings rose 8% to $1.6 billion but it expects third-quarter bookings to fall 14–18%.
- Can Meta AI Break Into The Enterprise? Why Zuckerberg Thinks So
Related markets
Latest news
- One of this year's most important relationships in global financial markets is falling apart
One of the most important relationships in global markets has started to unravel over the past couple of weeks. Investors are scrambling to work out what it could mean for the economy and their portfolios.
- 2 High-Flying Dividend Stocks to Buy and Hold for a Decade
The article argues healthcare is rebounding in 2026, with Merck (MRK) shares up 39% and AbbVie (ABBV) up 24% year to date, versus about 12% for the S&P 500. Merck's second-quarter revenue rose 5% to $16.6 billion, beating estimates, with Keytruda sales of $8.4 billion, though Keytruda may lose patent exclusivity by 2028. AbbVie's second-quarter revenue grew 10.2% to nearly $17 billion and adjusted EPS rose 22.9% to $3.65, driven by Skyrizi and Rinvoq sales growing about 24%. AbbVie is on a streak of 54 consecutive annual dividend increases, including its time as part of Abbott Laboratories, qualifying it as a Dividend King. The author concludes both are attractive long-term holdings based on financial results, pipelines, and dividends.
- Nvidia (NVDA) Stock Price Lags Massive Earnings Growth—A Compelling Value Opportunity
Munro Partners' Munro Global Growth Fund posted a -12.6% net return in Q3 2026, trailing the MAET.ASX return of -13.8%, with long holdings the main detractors. The fund's letter named NVIDIA (NASDAQ:NVDA) its largest contributor, citing strong earnings growth and guidance for at least 70% revenue growth next fiscal year, versus consensus of 45%. Nvidia reported quarterly revenue of USD96.2bn in August, up 106% year on year, and management said growth would have been closer to 100% without supply constraints. As of October 12, 2026, NVDA closed at $214.13, down 4.23% over the past month and up 19.23% over the past year, with a $5.16 trillion market cap and a 52-week range of $164.27 to $243.37. The fund says demand for semiconductors and AI remains strong, creating a constructive setup as capex and political fears are now priced in.
- Better Artificial Intelligence Stock for 2026: C3.ai vs. SentinelOne
The article compares C3.ai, which sells enterprise AI applications, with SentinelOne, which provides AI-powered autonomous cybersecurity. In fiscal 2026 (ended April 30), C3.ai's revenue was nearly $250.3 million, down 35.7%, with a net loss of $470.4 million and negative free cash flow of $190.7 million. SentinelOne's fiscal 2026 (ended January 31) revenue reached $1.0 billion, up 21.9%, with a net loss of $450.7 million and free cash flow of about $75.9 million, though stock-based compensation equaled roughly 388.4% of operating cash flow. The article cites C3.ai's restructuring plan from February 2026 and long government sales cycles as risks, and SentinelOne's competition from larger vendors and reliance on Amazon hosting. It says SentinelOne trades at a lower valuation relative to sales, while C3.ai has no future earnings estimates.
- Salazar Resources to Begin Drilling the Yumi Gold-Silver Veins at Tarqui, with Porphyry Drilling Planned at Monja, Ecuador
Salazar Resources closed a $3,500,000 non-brokered private placement announced on October 8, 2026, and outlined its exploration plan. Phase 1 is about 1,500 metres of drilling in five holes at the Yumi gold-silver veins on its 100%-owned Tarqui project, with drilling expected to begin in late October 2026, and the veins have not previously been drilled. Selective rock-chip samples returned 105 g/t Au and 1,038 g/t Ag, and historical BHP holes intersected porphyry-style mineralization nearby, which the company interprets as lying on the periphery of a porphyry center not yet located. Phase 2 contemplates up to about 3,500 metres of drilling in four holes at the 100%-owned Monja copper-gold porphyry target from the first quarter of 2027, subject to surface access and permits. A soil survey of about 895 samples is also planned at Quimi, part of the Tarqui-Quimi project.
- Musk: AI’s Hard Part Is “Scaling Power”: 3 Stocks Uniquely Suited to Win This New Bottleneck Trade
Microsoft said it will scale its Maia chips to multi-gigawatt deployments starting next calendar year, and Elon Musk said scaling power is the hard part of AI. The article argues power is an input that chip and app companies cannot copy quickly, which favors Vistra (VST), Constellation Energy (CEG) and GE Vernova (GEV). Vistra has lost nearly a fifth of its value over the past year even though its adjusted EBITDA rose to $5.91 billion, while Constellation's normalized EPS is expected to reach $13.29 in fiscal 2027. GE Vernova's revenue is expected to reach $60.7 billion by fiscal 2028, and Jefferies has a $298 price target on Vistra. The article warns that all three stocks could move with the mood around AI, regardless of their results.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.